{"abstract": "AbbVie said it had \u201cnot received any written commitments of support\u201d from shareholders of Shire for its latest takeover offer, which AbbVie has raised to about $51 billion.", "web_url": "https://dealbook.nytimes.com/2014/07/09/abbvie-backtracks-on-comments-in-shire-bid/", "snippet": "AbbVie said it had \u201cnot received any written commitments of support\u201d from shareholders of Shire for its latest takeover offer, which AbbVie has raised to about $51 billion.", "lead_paragraph": "LONDON \u2013 AbbVie on Wednesday retracted statements that shareholders of the Irish drug maker Shire were supportive of AbbVie\u2019s takeover bid.", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/07/09/business/dbpix-abbvie-ft/dbpix-abbvie-ft-articleLarge-v2.png", "height": 176, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2014/07/09/business/dbpix-abbvie-ft/dbpix-abbvie-ft-articleLarge-v2.png", "xlargewidth": 600, "xlargeheight": 176}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/07/09/business/dbpix-abbvie-ft/dbpix-abbvie-ft-jumbo-v2.png", "height": 183, "width": 623, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/07/09/business/dbpix-abbvie-ft/dbpix-abbvie-ft-superJumbo-v2.png", "height": 183, "width": 623, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2014/07/09/business/dbpix-abbvie-ft/dbpix-abbvie-ft-thumbStandard.png", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2014/07/09/business/dbpix-abbvie-ft/dbpix-abbvie-ft-thumbStandard.png", "thumbnailwidth": 75, "thumbnailheight": 75}}], "headline": {"main": "AbbVie Backtracks on Comments in Shire Bid", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Corporate Taxes", "rank": 1, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 3, "major": "N"}, {"name": "subject", "value": "Stocks and Bonds", "rank": 4, "major": "N"}, {"name": "persons", "value": "Gonzalez, Richard", "rank": 5, "major": "N"}, {"name": "organizations", "value": "Abbott Laboratories", "rank": 6, "major": "N"}, {"name": "organizations", "value": "AbbVie Inc", "rank": 7, "major": "N"}, {"name": "organizations", "value": "JPMorgan Chase & Company", "rank": 8, "major": "N"}, {"name": "organizations", "value": "Shire PLC", "rank": 9, "major": "N"}, {"name": "glocations", "value": "Chicago (Ill)", "rank": 10, "major": "N"}, {"name": "glocations", "value": "Ireland", "rank": 11, "major": "N"}], "pub_date": "2014-07-09T09:30:10+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Chad Bray", "person": [{"firstname": "Chad", "middlename": null, "lastname": "Bray", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/14a5a88c-aa7e-5a12-a656-acb71a5803c7", "word_count": 426, "uri": "nyt://article/14a5a88c-aa7e-5a12-a656-acb71a5803c7"}